|
Originally published In Press as doi:10.1074/jbc.M003640200 on September 8, 2000
J. Biol. Chem., Vol. 275, Issue 49, 38206-38212, December 8, 2000
Mapping of a Minimal Apolipoprotein(a) Interaction Motif
Conserved in Fibrin(ogen) - and -Chains*
Regina
Klose ,
Friedrich
Fresser ,
Silvano
Köchl §,
Walther
Parson§,
Andreas
Kapetanopoulos ,
Jamila
Fruchart-Najib¶,
Gottfried
Baier , and
Gerd
Utermann
From the Institute for Medical Biology and Human
Genetics, Universität Innsbruck, 6020 Innsbruck, Austria, the
§ Institute for Legal Medicine, Universität Innsbruck,
6020 Innsbruck, Austria, and the ¶ U325 INSERM, Departement
d'Athérosclérose, Institut Pasteur de Lille,
59019 Lille Cedex, France
Lipoprotein(a) (Lp(a)) is a major independent
risk factor for atherothrombotic disease in humans. The physiological
function(s) of Lp(a) as well as the precise mechanism(s) by which high
plasma levels of Lp(a) increase risk are unknown. Binding of
apolipoprotein(a) (apo(a)) to fibrin(ogen) and other components of the
blood clotting cascade has been demonstrated in vitro, but
the domains in fibrin(ogen) critical for interaction are undefined. We
used apo(a) kringle IV subtypes to screen a human liver cDNA
library by the yeast GAL4 two-hybrid interaction trap system. Among
positive clones that emerged from the screen, clones were identified as
fibrinogen - and -chains. Peptide-based pull-down experiments
confirmed that the emerging peptide motif, conserved in the
carboxyl-terminal globular domains of the fibrinogen and modules specifically interacts with apo(a)/Lp(a) in human plasma as
well as in cell culture supernatants of HepG2 and Chinese hamster
ovary cells, ectopically expressing apo(a)/Lp(a). The influence
of lysine in the fibrinogen peptides and of lysine binding sites in
apo(a) for the interaction was evaluated by binding experiments with apo(a) mutants and a mutated fibrin(ogen) peptid. This confirmed the
lysine binding sites in kringle IV type 10 of apo(a) as the major
fibrin(ogen) binding site but also demonstrated lysine-independent interactions.
*
This work was supported in part by grants from the EC-Biomed
2 shared cost project P95-0898, the Austrian "Fond zur
Förderung der wissenschaftlichen Forschung" (P11695-MED and
P12819-GEN), and the "Legerlotz-Stiftung" and Austrian Federal Bank
Grant 7665/1.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Inst. for Medical
Biology and Human Genetics, Schoepfstr. 41, A-6020 Innsbruck, Austria.
E-mail: Gottfried.Baier@uibk.ac.at.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Tsurupa, B. Ho-Tin-Noe, E. Angles-Cano, and L. Medved
Identification and Characterization of Novel Lysine-independent Apolipoprotein(a)-binding Sites in Fibrin(ogen) {alpha}C-domains
J. Biol. Chem.,
September 26, 2003;
278(39):
37154 - 37159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Busso, J. Dudler, R. Salvi, V. Peclat, V. Lenain, S. Marcovina, R. Darioli, P. Nicod, A. K. So, and V. Mooser
Plasma Apolipoprotein(a) Co-Deposits with Fibrin in Inflammatory Arthritic Joints
Am. J. Pathol.,
October 1, 2001;
159(4):
1445 - 1453.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|